Published in Hepatitis Weekly, February 11th, 2002
"Recently, the use of HIV-1 specific non-nucleoside reverse transcriptase inhibitors (NNRTIs), including nevirapine (NVP) and efavirenz (EFV), has been associated with severe hepatic injury," Johns Hopkins University, Baltimore, Maryland researchers said in Hepatology.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly